New wrinkle treatment takes on botox in major trial
NCT ID NCT06585696
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new injection called CU-20101 for moderate to severe frown lines between the eyebrows. It involved 554 adults and compared CU-20101 to Botox, a standard treatment. The goal was to see if CU-20101 works as well and is safe, including with repeated use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLABELLAR FROWN LINES are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Peking University First Hospital
Beijing, Beijing Municipality, 200443, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.